Drugs / Ba253BINEB
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02182583 | Oct 1998 → Jun 2000 | chronic obstructive pulmonary disease | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 3 | NCT02182635 | Aug 1998 → Mar 1999 | chronic obstructive pulmonary disease | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 3 | NCT02182661 | Jul 1998 → May 2000 | asthma | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ba253BINEB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02182661 ↗ |